Skip to main content

Table 1 Selection of trials included into our study

From: Evaluation of data completeness in the electronic health record for the purpose of patient recruitment into clinical trials: a retrospective analysis of element presence

Hospital

Study identifier

Disease

Parent population

Number of criteria

Münster

NCT01177033

intermittent claudication

299

18

Münster

NCT00976222

pigment epithelial detachment

3330

25

Münster

NCT00961142

acute leukemia

2065

39

Erlangen

NCT00866684

skin cancer

10589

21

Erlangen

NCT00025402

chronic myelogenous leukemia

1806

16

Erlangen

NCT00310583

mechanical hyperalgesia

4438

31

Heidelberg

NCT01165671

primary glioblastoma

22280

22

Heidelberg

NCT00176150

anorexia nervosa

22280

3

Heidelberg

NCT00750971

lupus erythematosus

22280

21

Düsseldorf

NCT00798525

critical illnesses

708

13

Düsseldorf

NCT00933374

urothelial carcinoma

2091

40

Düsseldorf

NCT00977132

myelodysplastic syndrome

2351

30

Gießen

DOI 10.1111/j.1365-2044.2012.07303.x

general anaesthesia

5500

7

Gießen

NCT01146821

sepsis

208

49

Gießen

DRKS00003264

abdominal surgery

5500

16

  1. Detailed legend: Each participating hospital selected 3 clinical trials, for which the study identifier, the disease under investigation, as well as the size of the parent population and the number of eligibility criteria are given in this table. Study identifiers beginning with NCT are related to clinicaltrials.gov and the identifier beginning with DRKS relates to the German register germanctr.de. One trial was not registered and thus has no identifier. For this study we show the digital object identifier (DOI) of the publication of the trial’s results. The parent population includes all patients admitted in the fourth quarter of 2011 to the clinical department that conducted the trial.